The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2001

Filed:

May. 27, 1994
Applicant:
Inventors:

Ching-Juh Lai, Bethesda, MD (US);

Michael Bray, Bethesda, MD (US);

Alexander G. Pletnev, Rockville, MD (US);

Ruhe Men, Kensington, MD (US);

Yi-Ming Zhang, Bethesda, MD (US);

Kenneth H. Eckels, Bethesda, MD (US);

Robert M. Chanock, Bethesda, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/04 ; C07H 2/104 ;
U.S. Cl.
CPC ...
C12N 7/04 ; C07H 2/104 ;
Abstract

The invention includes a chimeric virus for use in a vaccine preparation having a genome comprising nucleic acid sequences encoding at least one structural protein from one flavivirus and nucleic acid sequences encoding nonstructural protein from another flavivirus. The genome preferably includes mutations within the viral genome that reduce virus virulence and in a particularly preferred embodiment these vaccines are directed to flaviviruses such as dengue virus, tick-borne encephalitis virus and Japanese encephalitis virus. The invention also includes a baculovirus having a recombinant dengue cDNA sequence which encodes: (1) dengue virus capsid protein, pre-matrix protein, envelope glycoprotein and NS1 and NS2a nonstructural proteins or (2) dengue envelope glycoprotein or (3) dengue non-structural proteins NS1 and NS2a. The invention further includes a baculovirus having a recombinant Japanese B encephalitis virus cDNA sequence which encodes the Japanese B encephalitis virus capsid protein, pre-matrix protein, envelope glycoprotein and non-structural proteins NS1 and NS2a. The invention further includes a vaccine and a method to produce that vaccine.


Find Patent Forward Citations

Loading…